Arctic Bioscience AS Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	86	88	46	266	288	433
Market Cap Growth	21.81%	90.44%	-82.57%	-7.39%	-33.50%	-
Enterprise Value	147	141	28	157	110	174
Last Close Price	3.18	3.28	1.83	10.50	11.80	17.80
PS Ratio	2.01	2.08	1.05	7.89	8.35	20.10
PB Ratio	0.49	0.51	0.22	1.03	1.00	1.35
P/TBV Ratio	0.50	0.52	0.22	1.05	1.01	1.36
EV/Sales Ratio	3.44	3.31	0.64	4.64	3.19	8.08
Debt / Equity Ratio	0.36	0.36	0.10	0.01	-	0
Net Debt / Equity Ratio	0.35	0.35	0.09	-0.30	-0.50	-0.71
Net Debt / EBITDA Ratio	-1.99	-1.99	-0.46	1.80	4.65	6.08
Net Debt / FCF Ratio	-1.34	-1.34	-0.19	1.19	1.72	2.99
Asset Turnover	0.15	0.15	0.15	0.11	0.10	0.10
Inventory Turnover	0.99	0.99	0.95	0.70	0.71	0.57
Quick Ratio	0.24	0.24	0.43	2.53	4.03	11.40
Current Ratio	0.59	0.59	0.86	3.36	4.91	12.76
Return on Equity (ROE)	-21.36%	-21.36%	-20.43%	-16.68%	-11.20%	-22.15%
Return on Assets (ROA)	-7.41%	-7.41%	-9.80%	-9.67%	-6.49%	-11.48%
Return on Capital Employed (ROCE)	-16.60%	-16.60%	-21.40%	-18.60%	-12.10%	-12.50%
Earnings Yield	-47.86%	-46.40%	-103.25%	-17.09%	-11.83%	-9.84%
FCF Yield	-52.96%	-51.35%	-207.15%	-24.43%	-29.19%	-17.57%
Buyback Yield / Dilution	-6.42%	-6.42%	0.26%	-3.88%	-0.60%	-75.31%